The Gene Therapy Breakthrough: How Next-Generation Modalities are Poised to Reshape the Duchenne Muscular Dystrophy Market Valuation.
Duchenne Muscular Dystrophy (DMD) is a relentlessly progressive, X-linked genetic disorder caused by a lack of the functional dystrophin protein, leading to severe muscle wasting, loss of ambulation, and premature death due to cardiopulmonary failure. For decades, treatment focused on palliative and supportive care, primarily relying on corticosteroids to slow muscle degeneration. Today, the...
0 Comments 0 Shares 1K Views 0 Reviews